Cargando…
To Treat or Not to Treat: Low‐Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours
Autores principales: | Kam, Wayneho, Xian, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673693/ https://www.ncbi.nlm.nih.gov/pubmed/36129053 http://dx.doi.org/10.1161/JAHA.122.027238 |
Ejemplares similares
-
Effect of IV alteplase on the ischemic brain lesion at 24–48 hours after ischemic stroke
por: Mair, Grant, et al.
Publicado: (2018) -
Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022) -
Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022) -
Alteplase for Acute Ischemic Stroke Beyond 3 hours: Enthusiasm Outpaces Evidence
por: Garg, Ravi
Publicado: (2021) -
Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)